期刊文献+

与DRGs结合的临床路径管理效果评价 被引量:39

Evaluation of Clinical Pathway Management Effect Combined with Diagnosis Related Groups
下载PDF
导出
摘要 目的结合运用疾病诊断相关分组(Diagnosis Related Groups, DRGs)数据进行临床路径管理的效果评价。方法探讨结合DRGs数据对临床路径的实施效果进行评价。结果 (1)通过DRGs数据分析,可以看出治疗同等类型、同等难度病例,该医院所耗费用较低,住院时间也较短,总体效率较高。(2)路径管理病种的入径患者与未入径患者的平均住院天数比较,2014—2016年的平均住院天数数据经配对t检验,差异有统计学意义(P<0.05)。(3)路径管理病种的入径患者与未入径患者的平均费用比较,2014—2016年的平均住院费用数据经配对t检验,差异有统计学意义(P<0.05)。结论通过在该医院推广运用临床路径管理方法,使得临床路径的管理直接目的缩短平均住院天数、降低住院费用初见成效。 Objective To evaluate Clinical Pathway management in a hospital by using Diagnosis Related Groups.Methods Evaluating the effect of Clinical Pathway implementation in combination with DRGs(Diagnosis Related Groups)data.Results(1)It was showed that the cost of treatment of the same type and the same difficulty cases was lower,the hospitalization time was shorter,and the overall efficiency was higher in the hospital.(2)The average length of stay of patients with path management was compared with that of patients without access.The average length of stay in 2014,2015 and 2016 was analyzed by paired t test,and P<0.05 showed significant differences between the two groups.(3)Compared with the average cost of path management patients and the patients without access,the average hospitalization expenses from 2014 to 2016 were paired by t test,and P<0.05 indicated that there was signifi?cant difference between the two groups.Conclusion Through the promotion of Clinical Pathway management method in the hospital,the direct management of Clinical Pathway can shorten the average length of stay,and reduce the medical expenses.
作者 姚超 石佳 刘寂华 杨俊体 李贵华 YAO Chao;SHI Jia;LIU Ji-hua;YANG Junti;LI Guihua(Beijing Chuiyangliu Hospital,Beijing,100023,China)
出处 《中国医院管理》 北大核心 2018年第11期35-36,共2页 Chinese Hospital Management
基金 北京市朝阳区科技计划项目(CYSF181113)
关键词 疾病诊断相关分组 临床路径 评价 Diagnosis Related Groups(DRGs) Clinical Pathway evaluation
  • 相关文献

参考文献3

二级参考文献26

  • 1张亚东,高宪甫,马剑,王四平.医疗价格过快增长的供需原因与对策[J].中国卫生经济,2004,23(8):58-60. 被引量:15
  • 2林皓.医院市场特征的经济学综述[J].国外社会科学,2006(4):51-55. 被引量:9
  • 3林艺斌.行政垄断——过度医疗的病根[J].卫生经济研究,2006,23(8):10-10. 被引量:10
  • 4中国人民共和国卫生部.2010年中国卫生统计年鉴[M].北京:中国协和医科大学出版社,2010:211.
  • 5Iezzoni L. Risk adjustment for measuring health care outcomes[M]. 3rd ed. Chicago: Health Administration Press, 2003.
  • 6Francis HRF. Case mix use in 25 countries:a migration success but international comparisons failure[J]. International Journal of Medical Informatics, 2003, 70: 215-219.
  • 7Bala MV,Zarkin GA. Application of cost effectiveness analysis to multiple products: a practical guide[J]. Am J Manag Care, 2002, 8(3): 211 218.
  • 8Kattcy E. Two decades of casemix. Department of Health and Ageing[EB/OL]. [2011-09-14]. http://www. health. gov. au/ int ernet/main/publishing. nsf/Content.
  • 9Jian WY,Lu M, Cui T, et al. Evaluating performance of local case-mix system by international comparison: a case study in Beijing,China[J]. International Journal of Health Planning and Management, 2011, 26(4): 471-481.
  • 10Jian WY,Chan KY, Tang SN, et al. A case study of the coun terpart technical support policy to improve rural health services in Beijing. BMC Health Services Research 2012, 12[EB/OL]. [2012]. http://www. biomedcentral. com/content/pdf/1472-6963-12-482. pdf.

共引文献146

同被引文献361

引证文献39

二级引证文献309

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部